Skip to main content

Market Overview

Why Walgreens Could Be Valued At $71/Share In A Leveraged Buyout

Why Walgreens Could Be Valued At $71/Share In A Leveraged Buyout

Mizuho raised the potential takeout range in a possible leveraged buyout for Walgreens Boots Alliance Inc (NASDAQ: WBA) to as high as $71 a share, but said something closer to $67 is more likely.

The Analyst

Mizuho analyst Ann Hynes raised the potential takeout range to $64-$71 per share, up from an initial analysis projecting $60-$67 per share. Hynes has a Neutral rating on Walgreens with a $59 price target.

Hynes said there is a "willing debt market for a deal like WBA at an appropriate pro forma leverage." She said the most likely scenario analysis yields an internal rate of return of 23% for whomever might sponsor the LBO, if it happens.


Bloomberg reported recently KKR & Co Inc (NYSE: KKR) has approached Walgreens with a possible proposal for a take-private deal for the pharmacy chain that could be the biggest leveraged buyout in history. That followed a Reuters report that Walgreens was looking for possible private equity partners to take the company private.

See Also: A Closer Look At How A Walgreens Buyout Could Play Out

Analysts have said the deal would require at least $50 billion of debt to fund it.

That's out there, Hynes said.

"Based on conversations with our fixed income counterparties at Mizuho Securities, we believe there is a willing debt market for a deal like WBA," Hynes wrote in a note. "Given the size of the potential deal (roughly $70 billion), we suspect there would need to be more than one private equity player involved and management participation," noting current CEO Stefano Pessina owns about 16% of the outstanding Walgreens shares.

The Numbers

Hnes said a realistic pro forma leverage on such a big deal would be six times. With an equity investment of 37%, that yields a take-out share price of $67. Increasing the share of the debt that is from equity to 40% and keeping the six times pro forma leverage, you get to $71, Hynes said.

Mizuho believes, however, "the $67 range is more reasonable."

Deerfield, Illinois-based Walgreens, which operates Walgreens and Duane Reed pharmacies in the United States, and Boots in Great Britain, has a market capitalization of more than $56 billion and holds more than $16 billion in debt.

Price Action

Walgreens shares were down 0.43% Tuesday, trading at $61.69.

Photo credit: Mike Mozart, Flickr

Latest Ratings for WBA

Apr 2021Morgan StanleyMaintainsEqual-Weight
Apr 2021Credit SuisseMaintainsNeutral
Mar 2021Morgan StanleyMaintainsEqual-Weight

View More Analyst Ratings for WBA
View the Latest Analyst Ratings


Related Articles (WBA)

View Comments and Join the Discussion!

Posted-In: Ann Hynes Leveraged Buyout Mizuho Securities private equityAnalyst Color M&A Analyst Ratings Best of Benzinga

Latest Ratings

ETCredit SuisseMaintains13.0
IFRXCredit SuisseMaintains2.8
METCredit SuisseMaintains68.0
FLXNCredit SuisseMaintains14.0
ENPHCapital OneInitiates Coverage On175.0
View the Latest Analytics Ratings
Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at